Browse All
Displaying 1 - 1 of 1
Author:Reshef, Shoshana Smith, Gerald Harari, Ofir Gordon, Mark Ribalov, Rinat Lengil, Tamar Leo, Sam Willock, Rosa Zurita, Jose Furr-Stimming, Erin Sung, Victor
Session Name:P1: Movement Disorders: Huntington's Disease and Chorea 1
Topic:Movement Disorders
Program Number:P1.012
Author Institution:Teva Branded Pharmaceutical Products R&D, Inc., Epidemiology and Global Health Economics and Outcomes Research, Parsippany, NJ Cytel, Vancouver, BC, Canada Teva Branded Pharmaceutical Products R&D, Inc., Specialty Clinical Development, West Chester, PA Teva Pharmaceutical Industries Ltd., Global Health Economics and Outcomes Research, Tel Aviv, Israel Teva Pharmaceutical Industries Ltd., Global Medical Affairs, Tel Aviv, Israel Teva Branded Pharmaceutical Products R&D, Inc., Global Health Economics and Outcomes Research, Parsippany, NJ HCD Economics Ltd., Daresbury, United Kingdom HCD Economics Ltd., Cheshire, United Kingdom UTHealth, McGovern Medical School, Houston, TX University of Alabama At Birmingham, Birmingham, AL